Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

1.

Anti-inflammatory effects of an injectable copolymer of fatty acids (Ara 3000 beta®) in joint diseases.

Baugé C, Lhuissier E, Girard N, Quesnelle C, Ewert G, Boumediene K.

J Inflamm (Lond). 2015 Feb 23;12:17. doi: 10.1186/s12950-015-0062-7. eCollection 2015.

2.

Histone methylases as novel drug targets: developing inhibitors of EZH2.

Baugé C, Bazille C, Girard N, Lhuissier E, Boumediene K.

Future Med Chem. 2014;6(17):1943-65. doi: 10.4155/fmc.14.123.

PMID:
25495986
3.

Regulation and Role of TGFβ Signaling Pathway in Aging and Osteoarthritis Joints.

Baugé C, Girard N, Lhuissier E, Bazille C, Boumediene K.

Aging Dis. 2013 Dec 17;5(6):394-405. doi: 10.14336/AD.2014.0500394. eCollection 2014 Dec. Review.

4.

3-Deazaneplanocin A (DZNep), an inhibitor of the histone methyltransferase EZH2, induces apoptosis and reduces cell migration in chondrosarcoma cells.

Girard N, Bazille C, Lhuissier E, Benateau H, Llombart-Bosch A, Boumediene K, Bauge C.

PLoS One. 2014 May 22;9(5):e98176. doi: 10.1371/journal.pone.0098176. eCollection 2014.

5.

Enhanced hyaline cartilage matrix synthesis in collagen sponge scaffolds by using siRNA to stabilize chondrocytes phenotype cultured with bone morphogenetic protein-2 under hypoxia.

Legendre F, Ollitrault D, Hervieu M, Baugé C, Maneix L, Goux D, Chajra H, Mallein-Gerin F, Boumediene K, Galera P, Demoor M.

Tissue Eng Part C Methods. 2013 Jul;19(7):550-67. doi: 10.1089/ten.TEC.2012.0508. Epub 2013 Feb 19.

PMID:
23270543
6.

Molecular mechanism of hypoxia-induced chondrogenesis and its application in in vivo cartilage tissue engineering.

Duval E, Baugé C, Andriamanalijaona R, Bénateau H, Leclercq S, Dutoit S, Poulain L, Galéra P, Boumédiene K.

Biomaterials. 2012 Sep;33(26):6042-51. doi: 10.1016/j.biomaterials.2012.04.061. Epub 2012 Jun 6.

PMID:
22677190
7.

Type II TGFβ receptor modulates chondrocyte phenotype.

Baugé C, Duval E, Ollitrault D, Girard N, Leclercq S, Galéra P, Boumédiene K.

Age (Dordr). 2013 Aug;35(4):1105-16. doi: 10.1007/s11357-012-9433-7. Epub 2012 Jun 1.

8.

Regulatory mechanism of transforming growth factor beta receptor type II degradation by interleukin-1 in primary chondrocytes.

Baugé C, Girard N, Leclercq S, Galéra P, Boumédiene K.

Biochim Biophys Acta. 2012 May;1823(5):983-6. doi: 10.1016/j.bbamcr.2012.02.017. Epub 2012 Mar 8.

9.

Asporin expression is highly regulated in human chondrocytes.

Duval E, Bigot N, Hervieu M, Kou I, Leclercq S, Galéra P, Boumediene K, Baugé C.

Mol Med. 2011;17(7-8):816-23. doi: 10.2119/molmed.2011.00052. Epub 2011 Apr 25.

11.

Evaluation of adhesion, proliferation, and functional differentiation of dermal fibroblasts on glycosaminoglycan-coated polysulfone membranes.

Attia J, Legendre F, Nguyen QT, Baugé C, Boumediene K, Pujol JP.

Tissue Eng Part A. 2008 Oct;14(10):1687-97. doi: 10.1089/ten.tea.2007.0057.

PMID:
18823275
12.

Interleukin-1 and transforming growth factor-beta 1 as crucial factors in osteoarthritic cartilage metabolism.

Pujol JP, Chadjichristos C, Legendre F, Bauge C, Beauchef G, Andriamanalijaona R, Galera P, Boumediene K.

Connect Tissue Res. 2008;49(3):293-7. doi: 10.1080/03008200802148355. Review.

PMID:
18661363
13.

Interleukin-1beta up-regulation of Smad7 via NF-kappaB activation in human chondrocytes.

Baugé C, Attia J, Leclercq S, Pujol JP, Galéra P, Boumédiene K.

Arthritis Rheum. 2008 Jan;58(1):221-6. doi: 10.1002/art.23154.

14.

NFkappaB mediates IL-1beta-induced down-regulation of TbetaRII through the modulation of Sp3 expression.

Baugé C, Beauchef G, Leclercq S, Kim SJ, Pujol JP, Galéra P, Boumédiene K.

J Cell Mol Med. 2008 Sep-Oct;12(5A):1754-66. Epub 2007 Dec 10.

PMID:
18053089
15.
16.

Chondroitin sulfate modulation of matrix and inflammatory gene expression in IL-1beta-stimulated chondrocytes--study in hypoxic alginate bead cultures.

Legendre F, Baugé C, Roche R, Saurel AS, Pujol JP.

Osteoarthritis Cartilage. 2008 Jan;16(1):105-14. Epub 2007 Jul 12.

17.

Comparative effects of 2 antioxidants, selenomethionine and epigallocatechin-gallate, on catabolic and anabolic gene expression of articular chondrocytes.

Andriamanalijaona R, Kypriotou M, Baugé C, Renard E, Legendre F, Raoudi M, Boumediene K, Gatto H, Monginoux P, Pujol JP.

J Rheumatol. 2005 Oct;32(10):1958-67. Erratum in: J Rheumatol. 2005 Dec;32(12):2502.

PMID:
16206353
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk